View in EDS

P61 Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial.

Saved in:
Bibliographic Details
Title: P61 Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial.
Authors: Wolinsky, J.S.1 (AUTHOR), Hartung, H.P.1 (AUTHOR), Brochet, B.1 (AUTHOR), Montalban, X.1 (AUTHOR), Naismith, R.T.1 (AUTHOR), Manfrini, M.1 (AUTHOR), Garas, M.1 (AUTHOR), Model, F.1 (AUTHOR), Hubeaux, S.1 (AUTHOR), Kappos, L.1 (AUTHOR), Hauser, S.L.1 (AUTHOR)
Source: Clinical Neurophysiology. Aug2019, Vol. 130 Issue 8, pe170-e171. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 137324813
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: P61 Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wolinsky%2C+J%2ES%2E%22">Wolinsky, J.S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hartung%2C+H%2EP%2E%22">Hartung, H.P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brochet%2C+B%2E%22">Brochet, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Montalban%2C+X%2E%22">Montalban, X.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naismith%2C+R%2ET%2E%22">Naismith, R.T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Manfrini%2C+M%2E%22">Manfrini, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garas%2C+M%2E%22">Garas, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Model%2C+F%2E%22">Model, F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hubeaux%2C+S%2E%22">Hubeaux, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kappos%2C+L%2E%22">Kappos, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hauser%2C+S%2EL%2E%22">Hauser, S.L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+Neurophysiology%22">Clinical Neurophysiology</searchLink>. Aug2019, Vol. 130 Issue 8, pe170-e171. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=137324813
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clinph.2019.04.704
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: e170
    Titles:
      – TitleFull: P61 Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wolinsky, J.S.
      – PersonEntity:
          Name:
            NameFull: Hartung, H.P.
      – PersonEntity:
          Name:
            NameFull: Brochet, B.
      – PersonEntity:
          Name:
            NameFull: Montalban, X.
      – PersonEntity:
          Name:
            NameFull: Naismith, R.T.
      – PersonEntity:
          Name:
            NameFull: Manfrini, M.
      – PersonEntity:
          Name:
            NameFull: Garas, M.
      – PersonEntity:
          Name:
            NameFull: Model, F.
      – PersonEntity:
          Name:
            NameFull: Hubeaux, S.
      – PersonEntity:
          Name:
            NameFull: Kappos, L.
      – PersonEntity:
          Name:
            NameFull: Hauser, S.L.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 13882457
          Numbering:
            – Type: volume
              Value: 130
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Clinical Neurophysiology
              Type: main
ResultId 1